Minoryx Therapeutics
ID: 5637499Minoryx Therapeutics is a small Molecules for Rare Diseases founded in 2011.
13
Funding Rounds
$147.7m
Money raised
Recent Funding Rounds
Overview
Minoryx Therapeutics is a small Molecules for Rare Diseases founded in 2011.
- Website:
- Business model: B2B B2C
- Headquarters: Barcelona
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Minoryx Therapeutics has raised a total of $122.7m in funding over 13 rounds.
Key Insights:
- Minoryx Therapeutics Series C round: $51m
- Minoryx Therapeutics September 2018 Series B Funding Round: $22m
- Minoryx Therapeutics October 2015 Series A Funding Round: $20m
- Minoryx Therapeutics October 2015 Series A Funding Round: $20m
- Minoryx Therapeutics April 2015 Series A Funding Round: $790k
- Minoryx Therapeutics April 2015 Series A Funding Round: $790k
- Minoryx Therapeutics January 2015 Series A Funding Round: $1.6m
- Minoryx Therapeutics January 2015 Series A Funding Round: $1.6m
- Minoryx Therapeutics April 2013 Series A Funding Round: $1.5m
- Minoryx Therapeutics April 2013 Series A Funding Round: $1.5m
- Minoryx Therapeutics Series A round: $1.92m
- Minoryx Therapeutics funding round, September 2018: $25m
Industries
Minoryx Therapeutics is active in the following industries: